MASSDEVICE ON CALL — Wall Street analyst and Motley Fool writer Sean Williams sees an Obamacare upside for the medical device industry, despite the doom and gloom forecast usually spurred by talk of the medical device tax.
Williams ceded that his opinion is "pure conjecture," but he speculated that the late surge in Obamacare enrollment may suggest a financial benefit to healthcare systems and thus an indirect boon to medical device companies as hospitals write off fewer bills as "noncollectable" and spend more on new technologies.
"Given the uncertainty surrounding the implementation of Obamacare most hospitals have held back on making large equipment purchases," Williams wrote. "This extra cash flow generated by a lower rate of uninsured patients could be the perfect impetus for hospital operators to differentiate themselves from competitors with state-of-the-art equipment."
The biggest beneficiaries may be companies with high-priced, specialized equipment, such as Intuitive Surgical (NSDQ:ISRG) with its da Vinci robot-assisted surgical systems and Accuray (NSDQ:ARAY), with it robot-assisted radiation therapy technology.
Medtech tax opposition grows in Indiana
Indiana medical device makers, government officials and others are increasingly taking on the medical device tax, with members of state and local governments calling for an end to the levy in recent weeks.
Cosmetic device gets a makeover
Australian medical device maker Equipment launched a redesigned version of its Dermapen needling device, an alternative to fractional lasers for treating pigmentation, scars, wrinkles and other skin-based cosmetic concerns.
Not enough kids in clinical trials?
Most medical devices approved for use in children were never tested for pediatric use, going instead to patients aged 18 and older before getting the FDA’s OK for kids.